Cytek Biosciences Inc.
CTKB | NASDAQ
$5.69
+$0.41 (+7.77%)
Sep 22, 2026, 1:25 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 90.85M | 98.72M | 167.3M | 296.6M | 364.62M | 165.23M |
Short-Term Investments | 170.68M | 179.15M | 95.11M | 44.55M | n/a | n/a |
Long-Term Investments | 1.6M | 1.6M | 1.6M | n/a | n/a | n/a |
Other Long-Term Assets | 5.1M | 3.16M | 1.79M | 2.96M | 1.67M | 1.09M |
Receivables | 72.13M | 60.59M | 56.12M | 50.88M | 29.63M | 18.1M |
Inventory | 48.43M | 43.89M | 60.88M | 48.15M | 32.17M | 23.02M |
Other Current Assets | 2.98M | 1.97M | 2.56M | 6.7M | 708K | 1.33M |
Total Current Assets | 392M | 396.45M | 392.06M | 454.02M | 431.73M | 208.62M |
Property-Plant & Equipment | 29.32M | 28.13M | 29.26M | 27.57M | 5.85M | 2.14M |
Goodwill & Intangibles | 33.52M | 36.79M | 39.27M | 14.48M | 14.88M | 750K |
Total Long-Term Assets | 69.55M | 103.05M | 102.4M | 65.46M | 31.57M | 11.36M |
Total Assets | 461.54M | 499.5M | 494.46M | 519.48M | 463.31M | 219.98M |
Account Payables | 6.41M | 5.53M | 3.03M | 4.81M | 3.03M | 2.94M |
Deferred Revenue | 29.57M | 26.61M | 24.13M | 14.54M | 8.1M | 4.29M |
Short-Term Debt | 6.3M | 4.66M | 565K | 580K | n/a | 2.77M |
Other Current Liabilities | 18.14M | 1.86M | 16.71M | 17.3M | 12.04M | 12.01M |
Total Current Liabilities | 77.8M | 67.66M | 56.23M | 49.04M | 33.18M | 26.54M |
Long-Term Debt | 525K | 1.05M | 1.65M | 2.27M | n/a | n/a |
Other Long-Term Liabilities | 9.09M | 11.4M | 18.91M | 17.18M | 14.95M | 206.02M |
Total Long-Term Liabilities | 42M | 36.1M | 45.17M | 44.89M | 24.74M | 209.47M |
Total Liabilities | 119.8M | 103.76M | 101.39M | 93.93M | 57.92M | 236.01M |
Total Debt | 23.74M | 17.02M | 14.14M | 18.09M | n/a | 2.77M |
Book Value | 341.74M | 395.74M | 393.06M | 425.55M | 405.39M | -16.03M |
Book Value Per Share | 2.68 | 3.03 | 2.91 | 3.07 | 3.03 | -0.12 |
Common Stock | 129K | 129K | 131K | 135K | 126K | 23K |
Retained Earnings | -101.74M | -35.2M | -29.18M | -17.03M | -19.61M | -22.61M |
Comprehensive Income | 2.24M | 16K | -1.28M | -697K | 897K | 65K |
Shareholders Equity | 341.74M | 395.74M | 393.06M | 425.3M | 405.04M | -16.03M |
Total Investments | 172.28M | 180.75M | 96.71M | 44.55M | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove CTKB